Optimizing assessments of quality of life in contemporary prostate cancer clinical trials

被引：0
|
作者：
Morgans, Alicia K. [1 ,2 ]
机构：
[1] Harvard Med Sch, Dept Med, 450 Brookline Ave,DA 09-930, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, 450 Brookline Ave,DA 09-930, Boston, MA 02215 USA
来源：
CANCER | 2024年 / 130卷 / 20期
关键词：
PATIENT-REPORTED OUTCOMES; THERAPY;
D O I：
10.1002/cncr.35485
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This editorial reviews the associations between quality of life (QOL) and prognosis in cancer clinical trials, and considers whether they may be different in the era of radioligand therapy. It also outlines novel approaches to QOL analysis that may enhance our ability to use patient-reported outcomes in treatment decisions more effectively in the future.
引用
收藏
页码：3406 / 3408
页数：3
相关论文
共 50 条
  • [1] Quality of life as an endpoint for clinical trials of prostate cancer
    Tannock, I
    ANNALS OF ONCOLOGY, 1998, 9 : 54 - 55
  • [2] Use of quality-of-life outcome assessments in current cancer clinical trials
    Gotay, CC
    Wilson, M
    EVALUATION & THE HEALTH PROFESSIONS, 1998, 21 (02) : 157 - 178
  • [3] Methodologic assessments of quality of life measures in clinical trials
    Kong, SX
    Gandhi, SK
    ANNALS OF PHARMACOTHERAPY, 1997, 31 (7-8) : 830 - 836
  • [4] Quality of life assessments in clinical trials: methods and practice
    Dolan, P
    HEALTH ECONOMICS, 1998, 7 (06) : 562 - 562
  • [5] Quality of Life Assessments Utilized in Vitiligo Clinical Trials
    Pathak, Gaurav N.
    Chandy, Rithi J.
    Naini, Vidisha
    Feldman, Steven R.
    Rao, Babar K.
    DERMATOLOGIC THERAPY, 2023, 2023
  • [6] Guidelines for reporting results of quality of life assessments in clinical trials
    Staquet, M
    Berzon, R
    Osoba, D
    Machin, D
    QUALITY OF LIFE RESEARCH, 1996, 5 (05) : 496 - 502
  • [7] Health-related quality of life outcomes in prostate cancer prevention clinical trials
    Moinpour, Carol M.
    Darke, Amy K.
    Ganz, Patricia
    Klein, Eric
    Thompson, Ian
    QUALITY OF LIFE RESEARCH, 2014, 23 : 6 - 6
  • [8] HTA AGENCIES' PREFERENCES REGARDING QUALITY OF LIFE MEASURES FOR PROSTATE CANCER CLINICAL TRIALS
    Peeters, P.
    Casamayor, M.
    Moise, P.
    Holmstrom, S.
    VALUE IN HEALTH, 2011, 14 (03) : A170 - A171
  • [9] Quality of Life Assessments as Inclusion Criteria in Heart Failure Clinical Trials
    Dimond, Matthew
    Khan, Mohammad S.
    Fiuzat, Mona
    Cleland, John G.
    Bhatt, Ankeet
    Psotka, Mitchell
    Anker, Stefan D.
    Butler, Javed
    Felker, Michael
    Mark, Daniel B.
    Carson, Peter E.
    Abraham, William T.
    Ahmad, Tariq
    Lindenfeld, Joann
    Vaduganathan, Muthiah
    Whellan, David J.
    Vardeny, Orly
    Solomon, Scott
    Lewis, Eldrin F.
    Filippatos, Gerasimos
    OConnor, Christopher M.
    CIRCULATION, 2023, 148
  • [10] QUALITY-OF-LIFE ASSESSMENTS IN CLINICAL-TRIALS - SPILKER,B
    SULLIVAN, G
    HOSPITAL AND COMMUNITY PSYCHIATRY, 1990, 41 (12): : 1361 - 1362
12345